In comparison to normal controls, the AD patient group exhibited upregulation of CD4 naive T cells, regulatory T cells (Tregs), and resting Natural Killer cells (NK cells), while downregulating CD8 T cells and activated NK cells (Fig 4A). This evidence concerns the gene CD4 and Alzheimer disease.